FDA Approves Signos' First Glucose Monitoring System for Weight Loss

The FDA has approved Signos' glucose monitoring system for weight loss, offering an accessible, AI-driven solution that uses continuous glucose monitors to provide real-time data and personalized recommendations, aiming to help Americans manage their weight more effectively and affordably.